May 6, 2026 04:21AM Avalo Therapeutics Inc. (AVTX) PT Raised to $62 at Citizens on Abdakibart Potential

Apr 29, 2026 06:58AM Oppenheimer Reiterates Outperform Rating on Avalo Therapeutics Inc. (AVTX)

Apr 6, 2026 02:07AM Citizens Starts Avalo Therapeutics Inc. (AVTX) at Market Outperform

Mar 25, 2026 06:55AM Avalo Therapeutics Inc. (AVTX) PT Raised to $40 at H.C. Wainwright

Mar 23, 2026 03:50PM BTIG stays Buy on Avalo Therapeutics Inc. (AVTX) in anticipation of Ph2 abdakibart data

Mar 23, 2026 02:01PM Avalo Therapeutics Inc. (AVTX) PT Raised to $29 at Wedbush

Mar 23, 2026 12:40PM Guggenheim on Avalo (AVTX): 'Phase II LOTUS Study Readout in HS Remains On-Track for 2Q26 (Likely in May, Per Our Est)'

Feb 24, 2026 09:14AM TD Cowen on Avalo Therapeutics (AVTX): 'Risk/Reward Skewed To Significant Upside For AVTX-009 Phase II'

Feb 2, 2026 06:09AM Guggenheim Starts Avalo Therapeutics Inc. (AVTX) at Buy

Jan 15, 2026 06:45AM H.C. Wainwright Reiterates Buy Rating on Avalo Therapeutics Inc. (AVTX)

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 17, 2025 04:03PM Mizuho Starts Avalo Therapeutics Inc. (AVTX) at Outperform

Oct 1, 2025 07:00AM Avalo Therapeutics names Taylor Boyd chief business officer

Sep 18, 2025 06:58AM Avalo Therapeutics Inc. (AVTX) PT Raised to $25 at H.C. Wainwright

Sep 18, 2025 06:13AM Oppenheimer Reiterates Outperform Rating on Avalo Therapeutics Inc. (AVTX)

Sep 5, 2025 05:29AM TD Cowen Starts Avalo Therapeutics Inc. (AVTX) at Buy

Aug 15, 2025 06:10AM Cantor Fitzgerald Starts Avalo Therapeutics Inc. (AVTX) at Overweight

Aug 7, 2025 09:33AM Avalo Therapuetics (AVTX) Misses Q2 EPS by 192c

Jul 22, 2025 08:34AM Stifel Reiterates Buy Rating on Avalo Therapeutics Inc. (AVTX)

Jun 30, 2025 01:43PM BTIG Reiterates Buy Rating on Avalo Therapeutics Inc. (AVTX)

Jun 18, 2025 07:01AM Avalo Therapuetics (AVTX) Appoints Rita Jain to its Board

Jun 2, 2025 06:37AM H.C. Wainwright Assumes Avalo Therapeutics Inc. (AVTX) at Buy

May 13, 2025 06:27AM Avalo Therapuetics (AVTX) Misses Q1 EPS by 125c

Mar 26, 2025 07:02AM Avalo Therapuetics (AVTX) Appoints Michael Heffernan as Chairman of the Board

Mar 25, 2025 12:24AM Jefferies Starts Avalo Therapeutics Inc. (AVTX) at Buy

Mar 24, 2025 04:07PM Stifel Starts Avalo Therapeutics Inc. (AVTX) at Buy

Mar 24, 2025 06:32AM Oppenheimer Reiterates Outperform Rating on Avalo Therapeutics Inc. (AVTX)

Feb 28, 2025 06:28AM Piper Sandler Starts Avalo Therapeutics Inc. (AVTX) at Overweight

Jan 2, 2025 07:02AM Avalo Therapuetics (AVTX) Appoints Jennifer Riley as Chief Strategy Officer

Dec 19, 2024 06:05AM BTIG Starts Avalo Therapeutics Inc. (AVTX) at Buy

Nov 12, 2024 07:06AM Avalo Therapuetics (AVTX) Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants

Oct 8, 2024 12:29PM Oppenheimer Reiterates Outperform Rating on Avalo Therapeutics Inc. (AVTX)

Oct 8, 2024 07:01AM Avalo Therapuetics (AVTX) First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa

Aug 15, 2024 06:38AM Oppenheimer Reiterates Outperform Rating on Avalo Therapeutics Inc. (AVTX)

Aug 12, 2024 07:59AM Avalo Therapuetics (AVTX) Misses Q2 EPS by 1407c

Jul 16, 2024 07:01AM Avalo Therapuetics (AVTX) Appoints Mittie Doyle as Chief Medical Officer

Jul 9, 2024 07:02AM Avalo Therapuetics (AVTX) Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa

Jun 24, 2024 04:02PM Avalo Therapuetics (AVTX) Appoints Paul Varki as Chief Legal Officer